Gefitinib Sandoz

Gefitinib Sandoz is an oral medication used to treat certain types of cancer. It works by targeting specific proteins in cancer cells to slow their growth. This medication is manufactured by Sandoz Farmacéutica, S.A.

Gefitinib Sandoz is primarily used in the treatment of non-small cell lung cancer (NSCLC). It is designed for patients whose cancer has specific genetic features, such as mutations in the EGFR gene. This medication is part of a class of drugs known as tyrosine kinase inhibitors, which work by blocking the action of abnormal proteins that signal cancer cells to grow. What is Gefitinib Sandoz used for? It is used to manage and potentially shrink tumors in patients with advanced or metastatic NSCLC.

Common effects of Gefitinib Sandoz may include skin rash, diarrhea, and dry skin. Some patients may also experience nausea, vomiting, or appetite loss. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any persistent or bothersome effects with a healthcare provider.

Gefitinib Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Gefitinib Sandoz may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. This can affect how well the medication works or increase the risk of side effects. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Avoiding alcohol while taking Gefitinib Sandoz is generally recommended.